Federal contract award
HDTRA120C0045
APPLICATION OF A NANOCOMPLEX TECHNOLOGY TO THE ACTIVE PERMEATION OF THE BLOOD BRAIN BARRIER (BBB)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE THREAT REDUCTION AGENCY |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AD92 — OTHER DEFENSE - APPLIED RESEARCH/EXPLORATORY DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $7.6M |
| Current contract value | $7.6M |
| Potential contract value / ceiling | $12.2M |
| Start date | Jul 7, 2020 |
| Current end date | Jul 6, 2025 |
| Potential end date | Jul 6, 2025 |
| Latest award activity | Feb 11, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 11, 2025 | P00012 | $706.7K | APPLICATION OF A NANOCOMPLEX TECHNOLOGY TO PERMEATE THE BLOOD BRAIN BARRIER |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.